Healthcare


 AstraZeneca FTSE 100 agreement highlights healthcare sector trade alignment

AstraZeneca FTSE 100 agreement highlights healthcare sector trade alignment

October 13, 2025 11:19 AM BST| By Vivek Singh

AstraZeneca, a key FTSE 100 healthcare company, finalises a trade agreement centred on tariff alignment, enhancing operational continuity and global supply chain integration.

 UK FTSE 100 Update Indexftse Ukx Highlights Tech and Pharma Movements

UK FTSE 100 Update Indexftse Ukx Highlights Tech and Pharma Movements

October 13, 2025 08:09 AM BST| By Vivek Singh

FTSE 100 trends lower as Alphabet receives strategic market designation and AstraZeneca expands US operations, reflecting sector-specific activity in technology and healthcare.

 Genflow Biosciences Strengthens its Role in Longevity-Focused Healthcare Innovation

Genflow Biosciences Strengthens its Role in Longevity-Focused Healthcare Innovation

October 13, 2025 05:43 AM BST| By Team Kalkine Media

Genflow Biosciences (LSE:GENF) focuses on biotechnology and healthcare, with emphasis on longevity science, gene therapy innovation, and collaborative research driving advanced therapeutic development.

 GSK FTSE 100 Momentum Drives Market Focus

GSK FTSE 100 Momentum Drives Market Focus

October 10, 2025 01:43 PM BST| By Vivek Singh

GSK advanced above the two-hundred-day moving level, drawing heightened attention across the FTSE 100 index. This development placed renewed focus on London’s large-cap Healthcare Stocks segment.

 AstraZeneca (LSE:AZN) Developments Within FTSE 100 and FTSE 350 Healthcare

AstraZeneca (LSE:AZN) Developments Within FTSE 100 and FTSE 350 Healthcare

October 09, 2025 12:38 PM BST| By Vivek Singh

AstraZeneca (LSE:AZN) is a leading biopharmaceutical company featured in the FTSE 100 and FTSE 350 indices, with extensive research, global operations, and diverse treatment portfolios impacting healthcare innovation.

 Healthcare Sector Overview Highlighting Shield Therapeutics Across FTSE All Share

Healthcare Sector Overview Highlighting Shield Therapeutics Across FTSE All Share

October 07, 2025 09:06 AM BST| By Vivek Singh

Shield Therapeutics (LSE:STX), on the FTSE All Share, delivers healthcare and nutritional solutions through advanced manufacturing, compliance, and international distribution frameworks.

 Haleon (LSE:HLN) Earnings: Key Insights for Investors

Haleon (LSE:HLN) Earnings: Key Insights for Investors

October 06, 2025 07:49 AM BST| By Vivek Singh

Haleon (LSE:HLN) shows steady ROE and dividend reinvestment, providing insights into growth and stability in the FTSE 100 stock index.

 Feedback plc CEO Pay Sparks FTSE 100 Scrutiny

Feedback plc CEO Pay Sparks FTSE 100 Scrutiny

October 06, 2025 07:01 AM BST| By Vivek Singh

An in-depth look at Feedback plc (LSE:FDBK) performance, CEO remuneration, and shareholder concerns, with implications for the UK healthcare sector and FTSE 100 dynamics.

 FTSE 350 Index Features Baillie Gifford UK Growth Trust Operations

FTSE 350 Index Features Baillie Gifford UK Growth Trust Operations

October 05, 2025 10:43 AM BST| By Vivek Singh

Baillie Gifford UK Growth Trust (LSE:BGUK), part of the FTSE 350, manages UK equity portfolios with sector diversification, portfolio oversight, and operational management.

 Pharma Stocks Surge Following U.S. Drug Pricing Agreement

Pharma Stocks Surge Following U.S. Drug Pricing Agreement

October 01, 2025 09:28 AM BST| By Vivek Singh

Explore the recent surge in UK-listed pharmaceutical stocks following Pfizer's landmark drug pricing agreement with the U.S. government, and understand its implications for the industry.

 Tissue Regenix Group Performance Insights Amid FTSE All-Share Activity

Tissue Regenix Group Performance Insights Amid FTSE All-Share Activity

September 30, 2025 10:53 AM BST| By Vivek Singh

Tissue Regenix Group (LSE:TRX) operates within the regenerative medicine sector, advancing tissue engineering solutions. Positioned in the FTSE All-Share Index, the company engages in research, clinical applications.

 Smith & Nephew (LSE:SN) Debt Risk Management in FTSE 100

Smith & Nephew (LSE:SN) Debt Risk Management in FTSE 100

September 30, 2025 07:10 AM BST| By Sam

Analysis of Smith & Nephew (LSE:SN) highlights its debt management, balance sheet strength, and implications for FTSE 100 investors in the medical equipment sector.

 London Equities Reach New Heights as FTSE 100 Strengthens

London Equities Reach New Heights as FTSE 100 Strengthens

September 29, 2025 12:18 PM BST| By Vivek Singh

London’s FTSE 100 reached its highest level in weeks, with strong participation from financial, energy, industrial, and gold equities driving overall resilience.

 AstraZeneca Moves to NYSE While Maintaining London Listing

AstraZeneca Moves to NYSE While Maintaining London Listing

September 29, 2025 12:07 PM BST| By Vivek Singh

AstraZeneca’s NYSE listing enhances access to the US market while maintaining London presence, balancing global capital strategies with UK operations and research commitments.

 FTSE 100 Live London and European Markets Show Gains Ahead

FTSE 100 Live London and European Markets Show Gains Ahead

September 29, 2025 10:08 AM BST| By Vivek Singh

FTSE 100 live gains as GSK announces CEO change and European indices show steady performance while sterling strengthens, reflecting cautious market sentiment.

 GSK Leadership Change Signals Shift for FTSE 100 Today Live

GSK Leadership Change Signals Shift for FTSE 100 Today Live

September 29, 2025 09:02 AM BST| By Vivek Singh

GSK announces CEO transition to Luke Miels as Emma Walmsley steps down, while FTSE 100 Today Live and global indices reflect positive market trends.

 AnimalCare Group Expands Veterinary Services Across UK Markets

AnimalCare Group Expands Veterinary Services Across UK Markets

September 26, 2025 11:29 AM BST| By Vivek Singh

AnimalCare Group (LSE:ANCR) delivers comprehensive veterinary services across the UK, integrating technology, operational efficiency, and animal welfare under the FTSE AIM All-Share.

 Hikma Pharmaceuticals (LON:HIK): Short Interest Insights

Hikma Pharmaceuticals (LON:HIK): Short Interest Insights

September 26, 2025 08:24 AM BST| By Sam

This article provides an in-depth analysis of Hikma Pharmaceuticals PLC (LON:HIK), examining recent stock performance, short selling activity, financial metrics, and analyst perspectives to offer a comprehensive view of the company's market position.

 Hikma Pharmaceuticals (LSE:HIK) Performance in FTSE 100 View

Hikma Pharmaceuticals (LSE:HIK) Performance in FTSE 100 View

September 26, 2025 08:06 AM BST| By Sam

In-depth analysis of Hikma Pharmaceuticals (LSE:HIK), exploring its financial health, ROE, and strategic positioning within the FTSE 100 framework.

 FTSE 100 Index Today Pharma Sector in Focus Amid US Tariff

FTSE 100 Index Today Pharma Sector in Focus Amid US Tariff

September 26, 2025 07:53 AM BST| By Vivek Singh

The ftse 100 index today highlights pharmaceutical companies navigating new US tariff measures, with AstraZeneca leading expansion and operational compliance in the American market.

Recent Articles






Investing Tips

Previous Next